+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fusion Biopsy Market - Global Forecast 2026-2032- Product Image
Fusion Biopsy Market - Global Forecast 2026-2032- Product Image
Sale

Fusion Biopsy Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090089
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fusion Biopsy Market is projected to reach USD 865.80 Million in 2026. It is expected to continue growing at a CAGR of 7.77%, reaching USD 1.36 Billion by 2032.

Fusion Biopsy: Executive Overview

Fusion biopsy combines previously acquired medical imaging with real-time ultrasound guidance to improve targeting of suspicious lesions. In clinical practice, the approach is most closely associated with prostate biopsy, where MRI findings can be overlaid on ultrasound images to support targeted tissue sampling. Its relevance is shaped by the need to detect clinically significant disease while reducing unnecessary sampling and improving procedural confidence. Adoption depends on clinical evidence, equipment availability, workflow integration, reimbursement, operator training, and patient access to high-quality imaging.

How Fusion Biopsy Is Reshaping Diagnostic Pathways

The field is moving from predominantly systematic sampling toward risk-adapted pathways that use multiparametric imaging, targeted biopsy, and selective systematic cores. This transition places greater emphasis on standardized image acquisition, lesion scoring, data transfer, and multidisciplinary review. Improvements in ultrasound platforms, image registration, navigation software, and biopsy accessories are supporting more reproducible procedures, while evidence-based protocols are influencing how clinicians select patients and interpret results. Persistent challenges include inter-reader variation, registration errors, equipment costs, and unequal access to advanced imaging.

Artificial Intelligence Strengthens Image Interpretation and Procedure Support

Artificial intelligence is contributing to fusion biopsy through image-quality assessment, lesion detection, segmentation, risk classification, and workflow assistance. Machine-learning tools may help radiologists identify suspicious regions and improve consistency in assigning imaging scores, while procedure software can support targeting, registration, and documentation. However, clinical value depends on representative training data, transparent validation, interoperability, cybersecurity, and oversight of false-positive and false-negative results. AI should therefore augment, rather than replace, radiologist and urologist judgment, with performance monitored across devices, institutions, and patient populations.

Regional Dynamics Across the Fusion Biopsy Landscape

North America is characterized by established specialist networks, broad availability of advanced imaging in leading centers, and active attention to evidence and reimbursement. Europe benefits from structured clinical pathways and collaborative guideline development, although access varies across health systems. Asia-Pacific combines rapid investment in diagnostic infrastructure with substantial differences between metropolitan and rural care. Latin America is progressing through concentration of expertise in major urban centers, while affordability and referral capacity remain important considerations. The Middle East is expanding specialized hospital capabilities, and Africa faces greater constraints related to imaging access, trained personnel, maintenance, and referral logistics. Across all regions, implementation depends on adapting protocols to local resources and disease pathways.

What ASEAN, BRICS, the EU, G7, GCC, and NATO Groups Reveal

ASEAN countries present a mixed landscape in which private-sector tertiary hospitals may adopt advanced image-guided procedures faster than public systems, creating access differences. BRICS members span highly developed specialist centers and settings where imaging, pathology, and trained operators remain limited, making scalable protocols important. The European Union emphasizes harmonization, cross-border evidence, and health-technology assessment, while the G7 generally combines mature clinical infrastructure with scrutiny of outcomes, value, and data governance. GCC systems often have strong tertiary-care investment but may rely on concentrated specialist workforces. NATO members encompass diverse health systems, yet many share priorities around resilient supply chains, interoperable records, and standardized clinical training.

Country-Level Priorities in Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the UK, and the US

Australia and Canada must address geographic dispersion and referral coordination alongside specialist capability. Brazil, Mexico, and India face pronounced differences between urban tertiary centers and less-resourced settings, making training, affordability, and referral networks central. China, Japan, and South Korea have strong technology and hospital capabilities, with continued attention to standardization, workflow integration, and population-specific validation. France, Germany, Italy, and Spain operate within sophisticated European clinical and regulatory environments, where comparative evidence and pathway consistency remain important. The United Kingdom emphasizes protocol-driven care and health-system value. The United States has extensive specialist adoption and innovation activity, but access, reimbursement variation, and interoperability continue to influence implementation. Russia’s deployment is shaped by infrastructure distribution, procurement conditions, and availability of specialized expertise.

Practical Priorities for Leaders Building Reliable Fusion Biopsy Services

Industry leaders should begin with clearly defined clinical use cases and measurable outcomes, such as diagnostic yield, detection of clinically significant disease, complication rates, repeat-procedure frequency, and time from imaging to diagnosis. They should validate complete workflows rather than isolated devices, including imaging quality, data exchange, registration, targeting, pathology, and follow-up. Investment in structured training, credentialing, and multidisciplinary review can reduce operator variability. Organizations should also establish governance for AI, including local validation, bias assessment, audit trails, human oversight, and post-deployment monitoring. Partnerships with health systems should prioritize interoperability, transparent evidence, service support, and equitable access rather than technology acquisition alone.

Methodology for This Executive Summary

This executive summary uses the supplied market definition-fusion biopsy-as the analytical scope and synthesizes established clinical, technological, regulatory, and health-system themes relevant to image-guided tissue sampling. The assessment is organized across the requested regions, country groups, and countries, with emphasis on documented adoption conditions, workflow requirements, access barriers, and implementation priorities. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Because the supplied reference contained only the market name and identifier, no unsupported numerical findings or institution-level conclusions were introduced.

Conclusion: Scaling Fusion Biopsy Through Evidence and Equitable Implementation

Fusion biopsy is becoming an important component of targeted diagnostic pathways where high-quality imaging, coordinated clinical teams, and reliable procedural systems are available. Its benefits are most likely to be sustained when imaging interpretation, biopsy execution, pathology, and follow-up are managed as one pathway. AI can reinforce consistency and efficiency, but safe deployment requires validation, transparency, and professional oversight. The central strategic opportunity is not simply wider equipment deployment; it is the development of evidence-based, interoperable, and accessible services that deliver dependable diagnostic decisions across diverse health systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fusion Biopsy Market, by Types
7.1. Introduction
7.2. Cognitive Fusion
7.3. MRI-MRI Fusion
7.4. MRI-Ultrasound Fusion
8. Fusion Biopsy Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Biopsy Markers
8.2.2. Contrast Agents
8.2.3. Needles & Probes
8.2.4. Sterilization & Disinfection Kits
8.3. Equipment
8.3.1. Fusion Biopsy Systems
8.3.2. MRI Machines
8.3.3. Ultrasound Devices
9. Fusion Biopsy Market, by Procedure Type
9.1. Introduction
9.2. Transperineal Approach
9.3. Transrectal Approach
10. Fusion Biopsy Market, by End-User
10.1. Introduction
10.2. Diagnostic Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Fusion Biopsy Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Fusion Biopsy Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Fusion Biopsy Market, by Country
13.1. Introduction
13.2. United States
13.3. Germany
13.4. China
13.5. United Kingdom
13.6. India
13.7. Japan
13.8. Russia
13.9. Brazil
13.10. Canada
13.11. Italy
13.12. Mexico
13.13. France
13.14. Spain
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Biobot Surgical Pte Ltd
15.2. Canon Inc.
15.3. Eigen Health
15.4. Esaote SpA
15.5. Exact Imaging, Inc.
15.6. Focal Healthcare
15.7. Fujifilm Holdings Corporation
15.8. GE HealthCare Technologies Inc.
15.9. Hologic, Inc.
15.10. KOELIS SAS
15.11. Koninklijke Philips N.V.
15.12. MedCom GmbH
15.13. MTT GmbH
15.14. Siemens Healthineers AG
15.15. UC-Care Medical Systems
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Fusion Biopsy Market, Years Considered for the Study
FIGURE 2. Global Fusion Biopsy Market, Research Design
FIGURE 3. Global Fusion Biopsy Market, Research Framework
FIGURE 4. Global Fusion Biopsy Market, Data Triangulation
FIGURE 5. Global Fusion Biopsy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Fusion Biopsy Market Size, by Types, 2025 vs 2032 (%)
FIGURE 7. Global Fusion Biopsy Market Size, by Types, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Fusion Biopsy Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Fusion Biopsy Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Fusion Biopsy Market Size, by Procedure Type, 2025 vs 2032 (%)
FIGURE 11. Global Fusion Biopsy Market Size, by Procedure Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Fusion Biopsy Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Fusion Biopsy Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Fusion Biopsy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Fusion Biopsy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Fusion Biopsy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Fusion Biopsy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Fusion Biopsy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Fusion Biopsy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Fusion Biopsy Market Segmentation & Coverage
TABLE 2. Global Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 4. Global Cognitive Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cognitive Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cognitive Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global MRI-MRI Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global MRI-MRI Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global MRI-MRI Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global MRI-Ultrasound Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global MRI-Ultrasound Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global MRI-Ultrasound Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 14. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Biopsy Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Biopsy Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Biopsy Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Needles & Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Needles & Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Needles & Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Sterilization & Disinfection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Sterilization & Disinfection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Sterilization & Disinfection Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Fusion Biopsy Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Fusion Biopsy Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Fusion Biopsy Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global MRI Machines Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global MRI Machines Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global MRI Machines Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Ultrasound Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Ultrasound Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Ultrasound Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 42. Global Transperineal Approach Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Transperineal Approach Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Transperineal Approach Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Transrectal Approach Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Transrectal Approach Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Transrectal Approach Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 49. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 66. North America Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. North America Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 68. North America Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 69. North America Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 70. North America Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 71. North America Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 72. North America Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 73. Latin America Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Latin America Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 75. Latin America Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Latin America Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 77. Latin America Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 78. Latin America Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 79. Latin America Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 80. Europe Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Europe Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 82. Europe Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Europe Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 84. Europe Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 85. Europe Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 86. Europe Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 87. Middle East Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 89. Middle East Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Middle East Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 91. Middle East Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 92. Middle East Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 93. Middle East Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 94. Africa Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Africa Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 96. Africa Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Africa Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 98. Africa Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 99. Africa Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 100. Africa Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 101. Global Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. ASEAN Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 104. ASEAN Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. ASEAN Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 106. ASEAN Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 107. ASEAN Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 108. ASEAN Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 109. GCC Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. GCC Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 111. GCC Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. GCC Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 113. GCC Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 114. GCC Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 115. GCC Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 116. European Union Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. European Union Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 118. European Union Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. European Union Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 120. European Union Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 121. European Union Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 122. European Union Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 123. BRICS Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. BRICS Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 125. BRICS Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. BRICS Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 127. BRICS Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 128. BRICS Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 129. BRICS Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 130. G7 Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. G7 Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 132. G7 Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. G7 Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 134. G7 Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 135. G7 Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 136. G7 Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 137. NATO Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. NATO Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 139. NATO Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. NATO Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 141. NATO Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 142. NATO Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 143. NATO Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 144. Global Fusion Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. United States Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 146. United States Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 147. United States Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. United States Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 149. United States Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 150. United States Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 151. United States Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 152. Germany Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 153. Germany Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 154. Germany Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Germany Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 156. Germany Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 157. Germany Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 158. Germany Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 159. China Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 160. China Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 161. China Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. China Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 163. China Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 164. China Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 165. China Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 166. United Kingdom Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 167. United Kingdom Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 168. United Kingdom Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. United Kingdom Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 170. United Kingdom Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 171. United Kingdom Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 172. United Kingdom Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. India Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 174. India Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 175. India Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. India Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 177. India Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 178. India Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 179. India Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 180. Japan Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 181. Japan Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 182. Japan Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Japan Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 184. Japan Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 185. Japan Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 186. Japan Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. Russia Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 188. Russia Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 189. Russia Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Russia Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 191. Russia Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 192. Russia Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 193. Russia Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 194. Brazil Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 195. Brazil Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 196. Brazil Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. Brazil Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 198. Brazil Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 199. Brazil Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 200. Brazil Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 201. Canada Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 202. Canada Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 203. Canada Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. Canada Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 205. Canada Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 206. Canada Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 207. Canada Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 208. Italy Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 209. Italy Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 210. Italy Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Italy Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 212. Italy Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 213. Italy Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 214. Italy Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 215. Mexico Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 216. Mexico Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 217. Mexico Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Mexico Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 219. Mexico Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 220. Mexico Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 221. Mexico Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 222. France Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 223. France Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 224. France Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. France Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 226. France Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 227. France Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 228. France Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 229. Spain Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 230. Spain Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 231. Spain Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Spain Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 233. Spain Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 234. Spain Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 235. Spain Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 236. Australia Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 237. Australia Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 238. Australia Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Australia Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 240. Australia Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 241. Australia Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 242. Australia Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 243. South Korea Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 244. South Korea Fusion Biopsy Market Size, by Types, 2017-2032 (USD Million)
TABLE 245. South Korea Fusion Biopsy Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. South Korea Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 247. South Korea Fusion Biopsy Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 248. South Korea Fusion Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 249. South Korea Fusion Biopsy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 250. Global Fusion Biopsy Market Share, by Key Player, 2025
TABLE 251. Global Fusion Biopsy Market, Key Experts

Companies Mentioned

  • Biobot Surgical Pte Ltd
  • Canon Inc.
  • Eigen Health
  • Esaote SpA
  • Exact Imaging, Inc.
  • Focal Healthcare
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • KOELIS SAS
  • Koninklijke Philips N.V.
  • MedCom GmbH
  • MTT GmbH
  • Siemens Healthineers AG
  • UC-Care Medical Systems

Related Topics

Related Reports

Prostate Fusion Biopsy Market - Global Forecast 2026-2032 - Product Image

Prostate Fusion Biopsy Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Ultrasound Fusion Biopsy Market - Global Forecast 2026-2032 - Product Image

Ultrasound Fusion Biopsy Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Fusion Biopsy - Global Strategic Business Report - Product Image

Fusion Biopsy - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Fusion Biopsy - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Fusion Biopsy - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Fusion Biopsy Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product Type - Product Image

Fusion Biopsy Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product Type

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.